Works matching IS 13419625 AND DT 2023 AND VI 28 AND IP 9
Results: 15
Site of distant metastasis affects the prognosis with recurrent/metastatic head and neck squamous cell carcinoma patients treated with Nivolumab.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1139, doi. 10.1007/s10147-023-02381-3
- By:
- Publication type:
- Article
Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1200, doi. 10.1007/s10147-023-02383-1
- By:
- Publication type:
- Article
The efficacy of albumin–globulin ratio to predict prognosis in cancer patients.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1101, doi. 10.1007/s10147-023-02380-4
- By:
- Publication type:
- Article
Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1147, doi. 10.1007/s10147-023-02378-y
- By:
- Publication type:
- Article
Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106).
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1176, doi. 10.1007/s10147-023-02376-0
- By:
- Publication type:
- Article
Rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1129, doi. 10.1007/s10147-023-02374-2
- By:
- Publication type:
- Article
Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1166, doi. 10.1007/s10147-023-02373-3
- By:
- Publication type:
- Article
Morphological response and tumor shrinkage as predictive factors in metastatic colorectal cancer treated with first-line capecitabine, oxaliplatin, and bevacizumab.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1191, doi. 10.1007/s10147-023-02370-6
- By:
- Publication type:
- Article
Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1158, doi. 10.1007/s10147-023-02369-z
- By:
- Publication type:
- Article
Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1218, doi. 10.1007/s10147-023-02368-0
- By:
- Publication type:
- Article
Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1207, doi. 10.1007/s10147-023-02367-1
- By:
- Publication type:
- Article
Effect of a web-based fertility preservation training program for medical professionals in Japan.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1112, doi. 10.1007/s10147-023-02366-2
- By:
- Publication type:
- Article
Prescription patterns of analgesics in cancer patients with bone metastases in Japan: a retrospective database study.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1227, doi. 10.1007/s10147-023-02365-3
- By:
- Publication type:
- Article
Severe hypertension development significantly improves progression-free survival in regorafenib treatment for metastatic colorectal cancer.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1183, doi. 10.1007/s10147-023-02364-4
- By:
- Publication type:
- Article
The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 9, p. 1121, doi. 10.1007/s10147-023-02363-5
- By:
- Publication type:
- Article